In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1855 News Items found
Cancer biologist Andrea Ventura
In the Lab
Disorderly DNA: Researchers Simulate a Common Cause of Lung Cancer

MSK scientists have created a mouse model that replicates a subtype of non-small cell lung cancer caused by a chromosomal rearrangement.
A student asks a question at last year’s "Major Trends” seminar.
Event
A Sneak Preview of Our Annual “Major Trends” Seminar Live Webcast

Every year, MSK gives high school students and their teachers the opportunity to learn about cutting-edge biomedical research from our scientists.
Pictured: Pseudomonas aeruginosa
In the Lab
The Enemy’s Telltale Mark: Researchers Find Novel Way Body Defends against Harmful Bacteria

MSK researchers discover that the body senses and attacks harmful bacteria indirectly after the pathogens cause stress within the cells.
DNA wrapped around histones
Decoder
What Is Epigenetics?

Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.
Three friends
Support
10 Tips for Supporting a Friend with Cancer

Memorial Sloan Kettering social workers Meredith Cammarata and Liz Blackler give advice to anyone who wants to offer support to someone they know with cancer.
Pictured: Ping Chi
In the Lab
Molecular Studies Provide New Clues about Rare Soft Tissue Sarcoma

Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.
Pictured: Scott Lowe
In the Lab
Researchers Uncover Potential Target for “Undruggable” Form of Liver Cancer

In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.
Pictured: Experimental Brain Tumor
In the Lab
Genetic “Kill Switch” Could Make Cell Therapies Safer

Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.
MSK and Hartford leadership holding certificate
Announcement
MSK Cancer Alliance Grants Hartford HealthCare Cancer Institute Certified Member Status

The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute.
Stained pathology slides of a patient’s tumor (right) and of an organoid made from that tumor (left).
In the Lab
Prostate Cancer Organoids Provide New Tool for Evaluating Therapies

Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response.